Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US

More Jobs >>

Events

Partnerships in Clinical Trials 2012
March 4-7 — Orlando, FL
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Just Released: New Trends in Preventive and Therapeutic Vaccine
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia

More Events >>

Related Tags >> FDA Merck Gardasil Vaccine

sBLA News

Most Popular sBLA Story

Merck files for Gardasil indication for males

January 7, 2009 — 3:39pm ET | By Calisha Myers

Merck ended an otherwise rocky year on a good note. On announcing the successful completion of a Phase III study of the HPV vaccine Gardasil in young men in November, Merck said the company was on Read more...

sBLA Press Releases

Biogen Idec and Elan Receive Notification of PDUFA Date Extension
Genentech Submits Supplemental Application to FDA for Herceptin in Advanced HER2-Positive Stomach Cancer
ImClone Systems and Bristol-Myers Squibb Update the Status of Non-Small Cell Lung Cancer sBLA Submission
ERBITUX Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted To U.S. FDA
ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema

Latest Headlines

Merck files for Gardasil indication for males
January 7, 2009

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK